Target intelligence / Profile preview

Insulin dosing algorithm

Molecular classification
Other (specifically: algorithm, dosing support tool, software system; not a molecular entity)
01

Overview

An insulin dosing algorithm is a system—often embodied in software—that uses structured mathematical or clinical rules to assist healthcare providers (or automated insulin pumps) in recommending optimal insulin doses for patients with diabetes. These algorithms incorporate patient-specific factors such as real-time blood glucose, insulin sensitivity, carbohydrate intake, and clinical state to enhance the safety, effectiveness, and personalization of insulin therapy. They are used in inpatient and outpatient settings, help reduce dosing errors, and are foundational to technologies such as closed-loop (“automated insulin dosing”) systems and insulin dosing decision-support software. While not a molecular or receptor target, insulin dosing algorithms are critical tools in modern diabetes management.

Other names
insulin titration algorithmautomated insulin dosing algorithminsulin dosing softwareglycemic controllerinsulin dose adjustment algorithm
02

Mechanism of action

Not applicable (algorithms do not have pharmacological mechanisms); instead, algorithms calculate and recommend insulin doses based on clinical and biochemical parameters such as blood glucose, carbohydrate intake, prior insulin sensitivity, and other patient-specific data.

03

Biological functions

Not applicable in molecular biology; in clinical context: insulin dose optimization, glycemic control, therapy personalization, error reduction
04

Disease associations

Diabetes mellitus (type 1 and type 2), inpatient and outpatient glucose management
05

Safety considerations

Risk of hypoglycemia or hyperglycemia if algorithm dose recommendations are flawed or poorly implementedOverreliance on algorithmic recommendations without clinical oversightPotential data integration errors (e.g., from EMR, CGM)
06

Interacting drugs

Insulin and its analogs (e.g., insulin glargine, insulin detemir, insulin degludec, regular insulin, premixed insulin)
07

Biomarkers

Blood glucose levelTime-in-range (TIR, percent of readings between 70–180 mg/dL)Hemoglobin A1c (HbA1c)Presence/history of hypoglycemic or hyperglycemic events

Beyond the preview

Go deeper on Insulin dosing algorithm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin dosing algorithm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call